Cannabidiol modulation of oxidative stress and signalling

Cannabidiol (CBD), one of the primary non-euphoric components in the Cannabis sativa L. plant, has undergone clinical development over the last number of years as a therapeutic for patients with Lennox-Gastaut syndrome and Dravet syndromes. This phytocannabinoid demonstrates functional and pharmacol...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Sónia R., Hackett, Becky, O’Driscoll, David N., Sun, Melody Cui, Downer, Eric J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2021
Materias:
Cell Death & Injury
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385185/
https://www.ncbi.nlm.nih.gov/pubmed/34497718
http://dx.doi.org/10.1042/NS20200080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385185/
https://www.ncbi.nlm.nih.gov/pubmed/34497718
http://dx.doi.org/10.1042/NS20200080

Ejemplares similares